News
Can a Blood Test Detect Cancer in Asymptomatic Patients?
October 28, 2020Published in CURE Magazine
Read More ›10 Stocks to Buy as the Health-Care Revolution Races Ahead, According to Experts
September 25, 2020Published in Barron's
Read More ›‘Coming into their own’: FDA approval of liquid biopsy tests puts early, less invasive cancer detection in broader reach
September 3, 2020Published in USA Today
Read More ›Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months
August 12, 2020Published in Business Insider
Read More ›Don’t Let the Search for a COVID-19 Vaccine Hinder Solutions for Other Diseases
August 11, 2020Published in Morning Consult
Read More ›Test results in hand, Thrive raises $257M to push liquid biopsy toward approval
July 29, 2020Published in Endpoints
Read More ›Experimental blood test detects cancer in people who didn’t know they had it
April 30, 2020Published in CNN
Read More ›This Startup’s ‘Liquid Biopsy’ May Help Find Previously Undetected Cancers
April 28, 2020Published in Forbes
Read More ›Thrive Earlier Detection: FierceMedTech’s 2019 ‘Fierce 15’
March 9, 2020Published in FierceMedTech
Read More ›These Start-Ups are Racing to Help Doctors Detect Cancer Early with a Simple Blood Test
February 1, 2020Published on CNBC
Read More ›Eight Science Stories To Watch For In 2020
December 27, 2019Published in Los Angeles Times
Read More ›Cancer Is Still Beating Us—We Need a New Start
October 7, 2019Published in The Wall Street Journal
Read More ›This Oncologist Doesn’t Want Another Person to Die From a Cancer That Was Detected Too Late
October 3, 2019Published in FORTUNE
Read More ›To Catch Early Cancer, and Rivals, Thrive Banks on Hopkins Blood Test.
May 30, 2019Published in Xconomy
Read More ›Thrive’s quest to bring multicancer liquid biopsy test into routine clinical use.
May 30, 2019Published in BioCentury
Read More ›Cancer? This researcher says he can see it in your blood.
May 30, 2019Published in MIT Technology Review
Read More ›Exact Sciences Completes Acquisition Of Thrive Earlier Detection, Creating A Leader In Blood-Based, Multi-Cancer Screening
January 5, 2021 Read More ›Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screening
October 27, 2020 Read More ›Results From DETECT-A – The First Prospective, Interventional Study of a Blood-Based Multicancer Test
April 28, 2020 Read More ›Thrive Earlier Detection Strengthens Team with Key Appointments and Promotion
March 17, 2020 Read More ›FierceMedTech Names Thrive Earlier Detection as one of its “Fierce 15” Companies of 2019
March 9, 2020 Read More ›Thrive Earlier Detection Wins the BlueCross BlueShield Data Innovation Challenge
December 17, 2019 Read More ›Thrive Earlier Detection Announces Appointment of Seema Singh Bhan as Senior Vice President, Public Policy and External Affairs
September 23, 2019 Read More ›Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
April 28, 2020Published in Science. To request a copy of this publication, please contact publicationsthrv@exactsciences.com.
NOTE: The upload of the supporting raw data to the European Genome-phenome Archive (Study Accession ID EGAS00001004372) is in progress. In the interim, the data can be made available to investigators requiring urgent access by contacting either of the following co-authors: Ken Kinzler (kinzlke@jhmi.edu) or Isaac Kinde (publicationsthrv@exactsciences.com).
Detection and localization of surgically resectable cancers with a multianalyte blood test
February 23, 2018Published in Science
Detection and localization of surgically resectable cancers with a multianalyte blood test
February 23, 2018Published in Science Supplement